Provera and Betaseron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Provera (medroxyprogesterone acetate) and Betaseron (interferon beta-1b). Common drug interactions include migraine among females and breast cancer female among males.

The phase IV clinical study analyzes what interactions people have when they take Provera and Betaseron. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Provera?

Provera has active ingredients of medroxyprogesterone acetate. It is often used in birth control. eHealthMe is studying from 54,943 Provera users. Check the latest studies of Provera.

What is Betaseron?

Betaseron has active ingredients of interferon beta-1b. It is often used in multiple sclerosis. eHealthMe is studying from 26,886 Betaseron users. Check the latest studies of Betaseron.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

45 people who take Provera and Betaseron together, and have interactions are studied.

Provera and Betaseron drug interactions.

What are the common drug interactions of Provera and Betaseron, by gender? *:

female:

Migraine (headache)
Uterine haemorrhage (uterine bleeding)
Nausea (feeling of having an urge to vomit)
Palpitations (feelings or sensations that your heart is pounding or racing)
Dyspnoea (difficult or laboured respiration)
Hyperthyroidism (over activity of the thyroid gland)
Injection site reaction
Pain in extremity
Speech disorder
Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)

male:

Breast cancer female
Drug ineffective

What are the common drug interactions of Provera and Betaseron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Pyrexia (fever)

30-39:

Hyperthyroidism (over activity of the thyroid gland)
Nausea (feeling of having an urge to vomit)
Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
Dizziness
Hyperhidrosis (abnormally increased sweating)
Increased appetite
Pain in extremity
Pallor
Palpitations (feelings or sensations that your heart is pounding or racing)
Retching (strong involuntary effort to vomit)

40-49:

Abdominal pain
Fatigue (feeling of tiredness)
Abdominal distension
Device dislocation
Dysmenorrhoea (painful menstruation)
Lymphocyte count decreased
Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)
Migraine (headache)
Uterine haemorrhage (uterine bleeding)
Contusion (a type of hematoma of tissue in which capillaries)

50-59:

Chest pain
Dyspnoea (difficult or laboured respiration)
Coronary artery spasm
Dyspnoea exertional (breathlessness or shortness of breath)
Fatigue (feeling of tiredness)
Heart rate increased
Hepatic failure (liver failure)
Oesophageal disorder (disease of oesophagus)
Palpitations (feelings or sensations that your heart is pounding or racing)
Pancreatic carcinoma (pancreatic cancer)

60+:

Breast cancer female
Lymphoma (cancer that begins in immune system cells)
Injection site erythema (redness at injection site)
Injection site mass
Injection site pain
Injection site reaction
Lung infection
Lung neoplasm (tumour of lung)
Lung neoplasm malignant (cancer tumour of lung)
Metastases to lymph nodes (cancer spreads to lymph node)

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 7 people, 15.56%
Pain: 3 people, 6.67%
Migraine Without Aura (headache without neurological problems): 3 people, 6.67%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 3 people, 6.67%
Depression: 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Provera and Betaseron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously